TheProfitWatch

CLRB - Cellectar Biosciences INC NEW

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.94 -0.1 (-2.02%) --- --- --- --- 0.02 (0.4%) -0.24 (-4.72%) -0.24 (-4.72%)

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-3.39
Diluted EPS:
-3.39
Basic P/E:
-1.4277
Diluted P/E:
-1.4277
RSI(14) 1m:
100.0
VWAP:
4.84
RVol:
0.7285

Events

Period Kind Movement Occurred At
1m Price increase 1m 5.03 +0.08 (+1.62%) Oct 15 15:01
1m Price decrease 1m 4.85 -0.06 (-1.22%) Oct 15 11:50

Related News